Article Information
History
- November 14, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Christopher Collette, B.S.1,*,
- Gabrielle Willhelm, B.S.1,
- Victor A. Del Bene, Ph.D.1,
- Stephen L. Aita, Ph.D.2,
- Dario Marotta, B.S.1,
- Terina Myers, M.S.1,
- Joseph Anderson, B.S.1,
- Meredith Gammon, M.Ed.1,
- Adam Gerstenecker, Ph.D.1,
- L. Burt Nabors, M.D.1,4,
- John Fiveash, M.D.3,4 and
- Kristen L. Triebel, Psy.D.1,4
- 1Department of Neurology, the University of Alabama at Birmingham Heersink School of Medicine, Birmingham, AL, 35294, United States of America
- 2Geisel School of Medicine at Dartmouth, Hanover, NH, 03755, United States of America
- 3Department of Radiation Oncology, the University of Alabama at Birmingham Heersink School of Medicine, Birmingham, AL, 35233, United States of America
- 4O’Neal Comprehensive Cancer Center, the University of Alabama at Birmingham Heersink School of Medicine, Birmingham, AL, 35233, United States of America
- ↵*Corresponding Author:
Christopher Collette, BS, The University of Alabama at Birmingham, Sparks Center 650, 1720 7th Avenue South, Birmingham, Alabama, 35294-0017, Phone: (205) 934-2334, Fax: (205) 975-3094, ccollette{at}uabmc.edu
Posted November 14, 2022.
Cognitive Dysfunction in Non-CNS Metastatic Cancer: Comparing Brain Metastasis, Non-CNS Metastasis, and Healthy Controls
